A Dual GLP-1/GIP Receptor Agonist Is More Effective than Liraglutide in the A53T Mouse Model of Parkinson’s Disease

Figure 2

Testing spontaneous motor activity in the rotarod test. DA5-CH reduced the motor impairment better than liraglutide.  < 0.01 compared to the control group; ^# < 0.05 and ^## < 0.01 compared to the A53T saline-treated group. N = 12 per group.